Congratulations to senior Sharon Ong for being named an Intel semi-finalist in the Science and Talent Search. Ong was one of 300 semi-finalists selected from 1,744 total applicants.
Ong spent this past summer at NIH as an intern where she worked on the development of blue cone bipolar cells and the retina.
“[The purpose] is so later [in time], we can develop stem cell treatments for individuals with macular degeneration,” Ong said. “Macular degeneration is currently the leading cause of blindness in adults over the age of 55.”
Story continues below advertisement
